A group from the Shanghai Jiao Tong University School of Medicine has outlined a protocol for the tissue-resident myeloid populations […]
Young survivors of acute myeloid leukemia have long-term complications from treatment
Adolescent and young adult (AYA) patients treated for acute myeloid leukemia (AML) have a high risk of developing several long-term […]
Octogenarians with acute myeloid leukemia have poor survival
(HealthDay)—Octogenarians with acute myeloid leukemia (AML) have a one-month mortality rate of 41 percent and overall survival (OS) of 1.5 […]
FDA approves new treatment for acute myeloid leukemia
(HealthDay)—The U.S. Food and Drug Administration recently announced the approval of Daurismo (glasdegib) tablets for use in combination with a […]
Acute myeloid leukemia: New treatment overcomes chemo resistance
Investigators from the Ottawa Hospital and the University of Ottawa, both in Canada, saw that lack of a protein called […]